Close
ACHEMA MIDDLE EAST 2026

New Drug Explored For Epilepsy Gets $3M Funding In Australia

More than 150,000 Australians and 50 million people across the world are affected by epilepsy, with almost one-third finding it challenging to control the...

Faster Clinical Trial Nods Planned By The UK To Curb Issues

The UK government intends to make clinical trials more accessible in order to re-establish the country's reputation as a favoured location for pioneering research. In...

Pharma Drugs Gain From Tardigrade Proteins, Says Research

The study of how the microscopic creatures called tardigrades can survive extreme scenarios has led to a significant breakthrough that could go on to...

EMA Keeping A Close Watch On Critical Medicine Shortages

During its meeting in March 2023, the Management Board of the European Medicines Agency (EMA) gave an update on the continued efforts of the...

Pathways Laid Down By The CMS For Drug Price Negotiations

The Centers for Medicare & Medicaid Services issued preliminary instructions on March 15 on how it intends to negotiate medication pricing under Medicare, a...

Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

The combination of modulator therapies tezacaftor (TEZ) and ivacaftor (IVA) for cystic fibrosis (CF) has shown long-term safety as well as clinical benefit in...

Cell And Gene Therapy Boost With Novel UK Biotech Centres

The National Health Service Blood and Transplant from the UK, which takes care of blood as well as platelet donations as well as organ,...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...